Clinical Trial

Preoperative Education Program on Gastrointestinal Quality of Life in Cholecystectomy Patients

Study acronym: PEP-GIQLI
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate whether the comprehensive preoperative educational program for patients undergoing cholecystectomy can improve their knowledge and enhance postoperative quality of life compared to patients who receive routine preoperative intervention. The study focuses on patients who underwent cholecystectomy, particularly in the age range from 18 to 75 years, and aim to determine if comprehensive preoperative education has a greater impact on improving the quality of life level then routine intervention alone The main questions it aims to answer are 1. Does preoperative patient education improve postoperative quality of life scores more effectively than the routine intervention alone 2. Does the preoperative education improve the patient's knowledge and practices regarding the cholecystectomy operation? Researchers will compare patients who receive preoperative education to those receiving routine hospital intervention to assess the differences in postoperative quality of life score and patient outcomes. Participants will: Control group patients receive routine preoperative intervention, while the intervention group will participate in educational sessions on comprehensive preoperative education about gallstones and the cholecystectomy operation
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-24; most recent amendment 2026-02-04.
Trial Details
NCT Number NCT07380776
Lead Sponsor Hawler Medical University
Conditions Preoperative Patient Education , Quality of Life , Cholecystectomy
Enrollment 200 participants
Start Date 2025-02-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-06